Koehler, Viktoria Florentine
Achterfeld, Josefine
Sandner, Natalie
Koch, Christine
Wiegmann, Jonas Paul
Ivanyi, Philipp
Käsmann, Lukas
Pusch, Renate
Wolf, Dominik
Chirica, Mihaela
Knösel, Thomas
Demes, Melanie-Christin
Kumbrink, Joerg
Vogl, Thomas J.
Meyer, Gesine
Spitzweg, Christine
Bojunga, Joerg
Kroiss, Matthias
Funding for this research was provided by:
Munich Clinician Scientist Program Track FöFoLe+, medical faculty of the LMU Munich (Reg.-Nr. 044)
Universitätsklinik München
Article History
Received: 3 July 2023
Accepted: 4 July 2023
First Online: 7 August 2023
Declarations
:
: Viktoria F. Koehler has received honoraria for lectures and travel expenses from Novartis and Sanofi. Christine Koch received honoraria for advisory boards and lectures from Ipsen, Eisei, MSD, BMS, Astra Zeneca, Bayer. Philipp Ivanyi has received advisory fees from BMS, Bayer, ClinSol, Deciphera, EISAI, EMD-Serono, EUSA, H5-Oncology, Ipsen, Merck Serono (Global), Metaplan, MSD, Onkowissen, Pfizer, Roche, honoraria for lectures from AIM, Apogepha, Astra Zeneca, Astella, BMS, Bayer (+ Europe, Global), CORE2ED, Deciphera, DKG-Onkoweb, EISAI, EUSA, FoFM, Id-Institut, Ipsen (Europe), Merck Serono (+ Europe, Global), MSD, MedKom, MTE-Academy, MedWiss, New Concept Oncology, Onkowissen-tv.de, Pharma Mare, Pfizer, Roche, ThinkWired!, Schmitz-Communikation, StreamedUP!, Solution Academy, Vivantis, research grants from AIO, AstraZeneca, BMS, GSK, Ipsen, Lilly, Merck Serono, Niedersächsische Krebsgesellschaft, Novartis, EUSA, EISAI, Pfizer, MSD, Roche, Stiftung Immunonkologie, Wilhelm Sander Stiftung, travel grants from BB-Biotech, BMS, Bayer, Deutsche Gesellschaft für Thoraxchirurgie, EUSA, Ipsen, Merck, Pharma Mare, non-financial grants from Member of Germen Working Party Medical Oncology (AIO), Member of the German Cancer Society, ASCO Member, ESMO Member, Member of Oncological Working Party Hannover (OAK), Spokesman Interdisciplinary Working Party – Kidney Cancer (IAGN-DKG), Steering Board Immunooncology Cooperative Group (ICOG-H), Clinical Trail Streering Committee CCC-H. Lukas Käsmann has received honoraria for lectures from AMGEN and the German Cancer Society, and an unrestricted research grant from AstraZeneca. Melanie-Christin Demes received honoraria from talks and advisory board role from Amgen, AstraZeneca, Bayer, Biocartis, Diaceutics, Roche, Sophia Genetics und ThermoFisher. Christine Spitzweg has received honoraria for advisory boards and lectures from Ipsen, Lilly, Bayer, Eisai, Genzyme. Matthias Kroiss has received institutional research support from Ipsen, Loxo Oncology and Lilly, travel support from Eisai, Ipsen, HRA Pharma, MCI Germany and Lilly, honoraria for lectures from Bristol-Myers Squibb, Eisai, Lilly, and MSD and consultancy honoraria from Lilly and Bayer. Josefine Achterfeld, Natalie Sandner, Jonas Paul Wiegmann, Renate Pusch, Dominik Wolf, Mihaela Chirica, Thomas Knösel, Joerg Kumbrink, Thomas J Vogl, Gesine Meyer, and Joerg Bojunga have no competing financial interests.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University Würzburg [96/13] and subsequently by the ethics of all participating centers or by a waiver of informed consent, approved by the local institutional review boards for this minimal risk study.
: A waiver of informed consent was applicable.